BioLineRx Ltd.

BioLineRx Ltd.verified

BLRX

Price:

$3.37

Market Cap:

$14.29M

BioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology. Their leading investigational product, Motixafortide, a peptide, has successfully concluded pivotal Phase 3 clinical trials for mobilizing stem cells in autologous transplants, and Phase 2a trials targeting pancreatic cancer. This compound is currently progressing through Phase 2 studies for metastatic pancreatic adenocarcinoma and Phase 1b trials for acute respiratory distress syndrome linked to COVID-19 and other viral infections. Additionally, Motixafortide is being investigated for its therapeutic potential in solid tumors...[Read more]

Industry

Biotechnology

IPO Date

2011-07-27

Stock Exchange

NASDAQ

Ticker

BLRX

The Enterprise Value as of June 2026 (TTM) for BioLineRx Ltd. (BLRX) is 20.85M

According to BioLineRx Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.85M. This represents a change of 3.74% compared to the average of 20.10M of the last 4 quarters.

BioLineRx Ltd. (BLRX) Historical Enterprise Value (quarterly & annually)

How has BLRX Enterprise Value performed in the past?

The mean historical Enterprise Value of BioLineRx Ltd. over the last ten years is 53.46M. The current 20.85M Enterprise Value has changed 3.80% with respect to the historical average. Over the past ten years (40 quarters), BLRX's Enterprise Value was at its highest in in the December 2023 quarter at 123.94M. The Enterprise Value was at its lowest in in the March 2025 quarter at 13.80M.

Quarterly (TTM)
Annual

Average

53.46M

Median

42.97M

Minimum

19.28M

Maximum

111.50M

BioLineRx Ltd. (BLRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioLineRx Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 207.45%

Maximum Annual Enterprise Value = 111.50M

Minimum Annual Increase = -76.70%

Minimum Annual Enterprise Value = 19.28M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202519.28M-25.78%
202425.98M-76.70%
2023111.50M207.45%
202236.27M-56.74%
202183.83M145.22%
202034.18M22.41%
201927.92M-47.01%
201852.70M-43.46%
201793.22M87.63%
201649.68M-20.34%

BioLineRx Ltd. (BLRX) Average Enterprise Value

How has BLRX Enterprise Value performed in the past?

The current Enterprise Value of BioLineRx Ltd. (BLRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

52.25M

5-year avg

55.37M

10-year avg

53.46M

BioLineRx Ltd. (BLRX) Enterprise Value vs. Peers

How is BLRX’s Enterprise Value compared to its peers?

BioLineRx Ltd.’s Enterprise Value is less than Tharimmune, Inc. (66.84M), greater than GeoVax Labs, Inc. (292.14K), less than Adaptimmune Therapeutics plc (31.10M), greater than Apollomics, Inc. (13.15M), less than Adlai Nortye Ltd. (550.38M), greater than Aditxt, Inc. (3.97M), greater than Moleculin Biotech, Inc. (3.96M), greater than Ainos, Inc. (16.81M), greater than SeaStar Medical Holding Corporation (-559927.00), greater than Lunai Bioworks Inc. (9.18M),

Build a custom stock screener for BioLineRx Ltd. (BLRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioLineRx Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioLineRx Ltd. (BLRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioLineRx Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is BioLineRx Ltd.'s Enterprise Value?

What is the highest Enterprise Value for BioLineRx Ltd. (BLRX)?

What is the 3-year average Enterprise Value for BioLineRx Ltd. (BLRX)?

What is the 5-year average Enterprise Value for BioLineRx Ltd. (BLRX)?

How does the current Enterprise Value for BioLineRx Ltd. (BLRX) compare to its historical average?